Originally published by our sister publication Infectious Disease Special Edition
By Gina Shaw
Adding a collaborative practice agreement with pharmacists significantly accelerated initiation of long-acting, injectable pre-exposure prophylaxis (LAI-PrEP) for people at greatest risk for HIV infection, reported investigators with the EquiPrEP study at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans (poster 8-056).
EquiPrEP is an equity implementation science study launched in